Cargando…
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
Centronuclear myopathies (CNM) are non-dystrophic muscle diseases for which no effective therapy is currently available. The most severe form, X-linked CNM, is caused by myotubularin 1 (MTM1) loss-of-function mutations, while the main autosomal dominant form is due to dynamin2 (DNM2) mutations. We p...
Autores principales: | Tasfaout, Hichem, Buono, Suzie, Guo, Shuling, Kretz, Christine, Messaddeq, Nadia, Booten, Sheri, Greenlee, Sarah, Monia, Brett P., Cowling, Belinda S., Laporte, Jocelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467247/ https://www.ncbi.nlm.nih.gov/pubmed/28589938 http://dx.doi.org/10.1038/ncomms15661 |
Ejemplares similares
-
Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy
por: Biancalana, Valérie, et al.
Publicado: (2018) -
Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients
por: Koch, Catherine, et al.
Publicado: (2020) -
rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy
por: Ross, Jacob A., et al.
Publicado: (2020) -
Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy
por: Buono, Suzie, et al.
Publicado: (2022) -
Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)